SynBiotic SE · XETR:SBX
SynBiotic — Investor Presentation (May 2022)
19 slides from SynBiotic's investor presentation, May 2022
Slide 1: Company Presentation
Company Presentation May 2022 Building the sustainable cannabis platform in Europe. 1
Slide 2: Disclaimer and legal notice
Disclaimer and legal notice This presentation contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financ
Slide 3: Today's topics
01 Update on the cannabis legalisation Today´s topics 02 Recreational cannabis - a multi billion market 03 Synbiotic platform ideally positioned 04 Investment highlights 3
Slide 4: Cannabis is reality in a wide field of society in Germany
Cannabis is reality in a 30% 28 % wide field of society in Germany 20% 10% 7% max 4% max 1% 0% 12-month prevalence Lifetime prevalence Cannabis Others Source: DICE Study – November 2021 4
Slide 5: The legalisation of recreational cannabis in Germany is moving ahead
The legalisation of recreational cannabis in Germany is moving ahead 5
Slide 6: Taking a step back and looking at the US
Taking a step back and looking at the US 01 legal for consumption 01 01 legal for medical 01 02 01 02 01 02 purposes and 06 05 01 decriminalized 03 01 01 06 01 01 04 05 03 legal for medical 01 02 01 03 01 05 purposes 03 01 03 06 02 01 05 04 04 decriminalized 05 01 03 03 01 06 02 03 05 only use of C
Slide 7: Current situation in Germany
Current situation in Germany Today selling, owning and consuming Cannabis is Estimated black market in Germany of €4 billion illegal In practice ‘acceptance policy’ in some states where Cannabis is by far the most consumed illegal charges are not pressed (between 6 and 15 grams) substance and the pr
Slide 8: Sentiment is changing…
Sentiment is Agree rather Rather not agree 75% changing… ...now more in favour than against legalisation 50% 25% 0% Source: Statista 2014 2015 2016 2017 2018 2019 2020 2021 8
Slide 9: How can the legalisation concept look like?
How can the legalisation concept look like? Portioning? Data? Scope? Awareness? Limit disbursement to a Is a registration and data Full or limited Supported by awareness certain dose or not? 20- storage required? legalisation? Criminal law campaign? 30 grams available (Strafrecht) vs. regulatory law
Slide 10: Recreational cannabis in Germany - a multi billion market
Recreational cannabis in €4-7+ billion Germany - a multi based on Fiskalstudie - lower Turnover estimates for billion market recreational cannabis end conservative vs. upper following legalisation end not conservative* €5+ billion €4+ billion based on Colorado based on Canada extrapolation* extrapo
Slide 11: Significant take up and growth of recreational cannabis sale in North America
Significant take up and growth of recreational cannabis sale in North America Population California (USD Bn) Population Canada (CAN$ Bn) 38 Mio. 5 39 Mio. 3 4.4 2.6 4 2 3 2.8 1.2 2 1.3 1 1 0.2 0 0 2018 2019 2020 2018 2019 2020 Source: Statista 11
Slide 12: SynBiotic perfectly positioned through platform approach
SynBiotic perfectly positionend through platform approach Wellbeing & Medical Recreational Innovation & Health Cannabis Cannabis Biotech Supplement, food and Efficiency gains and Focus on a strong and Ensuring product cosmetics based on improvement of unit efficient distribution innovation and exist
Slide 13: Wellbeing – coherent portfolio to cover the value chain
Wellbeing – coherent portfolio to cover the value chain and cater for customer needs Solidmind Group GmbH 100% Ownership Hempro International GmbH 50,1% Ownership Supplement expert Producer, wholesaler and retailer of crude/ Creation and launch of brand raw material as well as finished product
Slide 14: Medical cannabis – Focus on distribution, network and know-how
Medical cannabis – Focus on distribution, network and know-how GECA Pharma GmbH MH medical hemp GmbH 100% Ownership 50,1 Ownership Import & sales of medicinal cannabis Production and sales of medicinal and products pharmaceutical cannabis products Canna Sales GmbH GreenLight Pharmaceutical LTD
Slide 15: Recreational cannabis – Giving legalisation a face
Recreational cannabis – Giving legalisation a face x Canna Abgabestellen Canna Abgabestellen Franchise GmbH Beteiligungs GmbH 50% BeteiligungSB 50,1% OwnershipSB Shop/ dispensary, IP and Operating investment vehicle franchise licence holding for owning and operating different shops 15
Slide 16: Key achievements & value creation
Key achievments & value creation €13 Mio. €15 Mio. 13 Platform Raised via two pro-forma Companies Vertically financings revenues in 2021 added to the integrated value (200% group chain compared to 2020) 16
Slide 17: Continued growth strategy in 2022 and beyond
Continued growth Plant based health movements bake us Build on structural drivers in our markets due to strategy in 2022 and ongoing awareness of mental health and wellbeing beyond Value added products Leverage our infrastructure and know-how to launch value added products Invest Invest in acquisiti
Slide 18: Share price development LTM - SynBiotic and peers
Share price development LTM - SynBiotic and peers SynBiotic Love Hemp Canopy Tilray Greenrise Cronos Group 100 % 75 % 50 % 25 % 0% -25 % -50 % -75 % -100 % Mai Jun Jul Aug Sep Okt Nov Dez 2022 Feb Mrz Apr Mai 18 Source: Yahoo Finance
Slide 19: Thank you!
Thank you! Contact us for any questions. Email Website office@synbiotic.com www.synbiotic.com 19